Research Article
Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy
Table 2
Disease characteristics and treatment response.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disease status at the start of therapy and investigator assessed response 4–12 weeks after therapy are presented. All patients were staged clinically, except patient 3, who was staged pathologically. PR: partial response, CR: complete response, SD: stable disease, PD: progressive disease, NED: no evidence of disease, IV: irradiated volume, and N/A: not applicable (because patient received adjuvant therapy no measureable disease for response assessment). |